A strategic rift has emerged among plaintiffs lawyers on how to pursue lawsuits over recalled heartburn medication Zantac, prompting lawsuits brought on behalf of tens of thousands of people to land in state courts across the country.
Nearly 200,000 people claim Zantac, recalled in 2019, caused a host of various cancers. But three years later, U.S. District Judge Robin Rosenberg, who is overseeing the multidistrict litigation in the Southern District of Florida, imposed new deadlines to file their lawsuits. At the same time, plaintiffs lawyers on the multidistrict litigation’s leadership team chose to limit their experts to those specializing in five specific types of cancer. As a result, many prominent plaintiffs firms, such as Los Angeles-based Baum Hedlund Aristei & Goldman, San Antonio’s Watts Guerra and Chicago’s Keller Postman, have turned to state courts, particularly in Delaware, New York, Pennsylvania, Illinois and California.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
